|
http://www.aarkstore.com/categories/index.asp Overactive Bladder - Pipeline Review, H2 2011 Summary Global Markets Direct, Overactive Bladder - Pipeline Review, H2 2011, provides an overview of the Overactive Bladder therapeutic pipeline. This report provides information on the therapeutic development for Overactive Bladder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Overactive Bladder. Overactive Bladder - Pipeline Review, H2 2011 is built using data and information sourced from Global Markets Direct proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Overactive Bladder. - A review of the Overactive Bladder products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Overactive Bladder pipeline on the basis of route of administration and molecule type. - Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Overactive Bladder. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players with the most promising pipeline. - Devise corrective measures for pipeline projects by understanding Overactive Bladder pipeline depth and focus of Overactive Bladder therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline. For more information, please visit :- Marketing Team Aarkstore Enterprise Phone:08149852585 Email:enquiry@aarkstore.com URL:www.aarkstore.com http://twitter.com/aarkstoredotcom http://in.linkedin.com/in/aarkstore http://www.facebook.com/aarkstoreenterprise http://www.aarkstore.com/reports/Overactive-Bladder-Pipeline-Review-H2-2011-161825.html More Related Reports :- Skin Rash - Pipeline Review, H2 2011 Renal Anemia - Pipeline Review, H2 2011 Overactive Bladder - Pipeline Review, H2 2011 Cough - Pipeline Review, H2 2011 Opium Addiction - Pipeline Review, H2 2011 Tetanus - Pipeline Review, H2 2011 Arrhythmias - Pipeline Review, H2 2011 Mucositis - Pipeline Review, H2 2011 Actinic Keratosis - Pipeline Review, H2 2011 Nosocomial Infections - Pipeline Review, H2 2011
Related Articles -
Overactive Bladder Pipeline Review Aarkstore, Market research reports, Market growth, Market size, Market trends, Market forecasts, Market analysis, M,
|
